MICHAEL HENDERSON - 09 Dec 2024 Form 4 Insider Report for Apogee Therapeutics, Inc. (APGE)

Role
Chief Executive Officer, Director
Signature
/s/ Matthew Batters, as attorney-in-fact for Michael Henderson
Issuer symbol
APGE
Transactions as of
09 Dec 2024
Transactions value $
$0
Form type
4
Filing time
11 Dec 2024, 20:02:57 UTC
Previous filing
06 Dec 2024
Next filing
10 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APGE Stock Option (Right to Buy) Award $0 +357,036 $0.000000 357,036 09 Dec 2024 Common Stock 357,036 $49.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents the right to purchase 357,036 shares of the Issuer's common stock, and will vest in forty-eight equal monthly installments over a four-year period from the date of grant, subject to the Reporting Person's continued service to the Issuer.